Immunovant, Inc.
IMVT
$13.84
-$1.38-9.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.78% | -15.55% | -11.86% | -8.04% | 155.97% |
| Total Receivables | 18.55% | -22.38% | -56.08% | 434.79% | -27.59% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.45% | 22.27% | 6.92% | 32.39% | -5.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -18.69% | -13.87% | -11.52% | -6.33% | 144.10% |
|
|
|||||
| Total Current Assets | -18.69% | -13.87% | -11.52% | -6.33% | 144.10% |
| Net Property, Plant & Equipment | 8.10% | 13.47% | 6.05% | -11.19% | -24.97% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.03% | -- | -- | -- | -- |
| Total Assets | -18.38% | -12.54% | -11.51% | -6.34% | 143.59% |
|
|
|||||
| Total Accounts Payable | -4.40% | 87.83% | 54.23% | 82.99% | -47.94% |
| Total Accrued Expenses | 5.66% | 35.28% | -17.88% | 48.10% | -13.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -51.06% | -31.88% | -50.00% | -54.90% | -50.16% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.49% | 48.06% | -7.39% | 51.42% | -20.26% |
|
|
|||||
| Total Current Liabilities | 2.49% | 48.06% | -7.39% | 51.42% | -20.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.49% | 48.06% | -7.39% | 51.42% | -20.26% |
|
|
|||||
| Common Stock & APIC | 0.96% | 0.92% | 0.98% | 0.78% | 50.52% |
| Retained Earnings | -10.87% | -11.95% | -10.55% | -10.04% | -7.36% |
| Treasury Stock & Other | 29.79% | 4.95% | -4.61% | 418.00% | -216.96% |
| Total Common Equity | -21.48% | -17.55% | -11.83% | -9.07% | 169.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.48% | -17.55% | -11.83% | -9.07% | 169.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.48% | -17.55% | -11.83% | -9.07% | 169.78% |
|
|
|||||